Omnicell Inc OMCL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Omnicell Appoints Nnamdi Njoku as Executive Vice President and Chief Operating Officer
-
Omnicell Announces Central Med Automation Service
-
Omnicell to Present at the 2024 Wells Fargo Healthcare Conference
-
EnlivenHealth® and Good Neighbor Pharmacy® Seek to Empower Independent Pharmacies with New Clinical Scope of Practice and Reimbursement Solution
-
Omnicell Announces Second Quarter 2024 Results
-
Omnicell to Release Second Quarter 2024 Financial Results on August 1, 2024
Trading Information
- Previous Close Price
- $42.33
- Day Range
- $42.68–43.73
- 52-Week Range
- $25.12–46.48
- Bid/Ask
- $41.02 / $68.54
- Market Cap
- $1.98 Bil
- Volume/Avg
- 336,612 / 563,973
Key Statistics
- Price/Earnings (Normalized)
- 28.87
- Price/Sales
- 1.82
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,590
- Website
- https://www.omnicell.com
Competitors
Valuation
|
Metric
|
OMCL
|
CAH
|
MCK
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.87 | 14.70 | 17.42 |
Price/Book Value | 1.65 | — | — |
Price/Sales | 1.82 | 0.12 | 0.21 |
Price/Cash Flow | 15.70 | 12.04 | 14.29 |
Price/Earnings
OMCL
CAH
MCK
Financial Strength
|
Metric
|
OMCL
|
CAH
|
MCK
|
|---|---|---|---|
Quick Ratio | 1.99 | 0.48 | 0.46 |
Current Ratio | 2.45 | 0.98 | 0.93 |
Interest Coverage | — | 24.55 | 14.09 |
Quick Ratio
OMCL
CAH
MCK
Profitability
|
Metric
|
OMCL
|
CAH
|
MCK
|
|---|---|---|---|
Return on Assets (Normalized) | 3.03% | 4.13% | 5.53% |
Return on Equity (Normalized) | 5.73% | — | — |
Return on Invested Capital (Normalized) | 2.80% | 109.00% | 64.65% |
Return on Assets
OMCL
CAH
MCK
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock
GEHC
| Sdqxskswz | Rcky | $42.0 Bil | |||
| Veeva Systems Inc Class A
VEEV
| Pdqszfgphd | Bzhqv | $34.1 Bil | |||
| Pro Medicus Ltd
PMCUF
| — | Dbqqty | $12.5 Bil | |||
| Solventum Corp
SOLV
| — | Mlslv | $11.7 Bil | |||
| Tempus AI Inc Class A common stock
TEM
| — | Wbgq | $8.3 Bil | |||
| Doximity Inc Class A
DOCS
| — | Xvbglz | $8.0 Bil | |||
| M3 Inc
MTHRF
| — | Yyybyz | $7.1 Bil | |||
| M3 Inc ADR
MTHRY
| — | Clghrg | $7.1 Bil | |||
| HealthEquity Inc
HQY
| — | Sdkqlb | $7.0 Bil | |||
| R1 RCM Inc
RCM
| — | Fcgc | $6.0 Bil |
United States